E-LIB Suche - Ergebnisse für: Cree, Bruce A. C.

1

Sphingosine 1‐phosphate receptor modulators in multiple scl..:

Coyle, Patricia K. ; Freedman, Mark S. ; Cohen, Bruce A...
Annals of Clinical and Translational Neurology. 11 (2024) 4 - p. 842-855 , 2024

Link: https://doi.org/10.1002/..

2

Temporal Relationship Between Serum Neurofilament Light Cha..:

Fox, Robert J. ; Cree, Bruce A.C. ; de Sèze, Jérôme...
Neurology. 102 (2024) 9 - p. , 2024

Link: https://doi.org/10.1212/..

3

Inflammatory and neurodegenerative serum protein biomarkers..:

Chitnis, Tanuja ; Qureshi, Ferhan ; Gehman, Victor M....
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

4

Safety and efficacy of inebilizumab for the treatment of ne..:

Cree, Bruce A C ; Kim, Ho Jin ; Weinshenker, Brian G...
The Lancet Neurology. 23 (2024) 6 - p. 588-602 , 2024

Link: https://doi.org/10.1016/..

5

Bioavailable central nervous system disease-modifying thera..:

Hartung, Hans-Peter ; Cree, Bruce A.C. ; Barnett, Michael...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

6

Herpes viral infection and the multiple sclerosis prodrome:..:

Cree, Bruce A C
Brain. 147 (2023) 1 - p. 7-9 , 2023

Link: https://doi.org/10.1093/..

7

Integration of epigenetic and genetic profiles identifies m..:

Ma, Qin ; Shams, Hengameh ; Didonna, Alessandro...
Communications Biology. 6 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

8

Multiple sclerosis: time for early treatment with high-effi..:

Selmaj, Krzysztof ; Cree, Bruce A. C. ; Barnett, Michael..
Journal of Neurology. 271 (2023) 1 - p. 105-115 , 2023

Link: https://doi.org/10.1007/..

9

Safety of the Concurrent Administration of Serotonergic Ant..:

Naismith, Robert T. ; Cohen, Jeffrey A. ; Bar-Or, Amit...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

10

Inébilizumab réduit le risque de poussée dans la NMOSD indé..:

Orhan, Aktas ; Bennett, Jeffrey L. ; Weinshenker, Brian G....
Revue Neurologique. 179 (2023) - p. S175-S176 , 2023

Link: https://doi.org/10.1016/..

11

Efficacy and safety of inebilizumab in Asian participants w..:

Fujihara, Kazuo ; Kim, Ho Jin ; Saida, Takahiko...
Multiple Sclerosis and Related Disorders. 79 (2023) - p. 104938 , 2023

Link: https://doi.org/10.1016/..

12

Design and Baseline Characteristics of Phase 3, Double-Blin..:

Montalban, Xavier ; Vermersch, Patrick ; Arnold, Douglas L....
Multiple Sclerosis and Related Disorders. 80 (2023) - p. 105328 , 2023

Link: https://doi.org/10.1016/..

13

Correlations Between Early MRI Parameters and Long-term Cli..:

Arnold, Douglas L. ; Freeman, Leorah ; Hartung, Hans-Peter...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

14

Long-term Safety of Ozanimod in Relapsing Multiple Sclerosi..:

Cree, Bruce A. C. ; Danese, Silvio ; Wolf, Douglas C....
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

15

SARS‐CoV‐2 vaccination and infection in ozanimod‐treated pa..:

Cree, Bruce A. C. ; Maddux, Rachel ; Bar‐Or, Amit...
Annals of Clinical and Translational Neurology. 10 (2023) 10 - p. 1725-1737 , 2023

Link: https://doi.org/10.1002/..